Maternal obesity alters feto-placental cytochrome P4501A1 activity

B. N. Dubois, P. O'Tierney-Ginn, J. Pearson, J. E. Friedman, Kent Thornburg, G. Cherala

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    Cytochrome P4501A1 (CYP1A1), an important drug metabolizing enzyme, is expressed in human placenta throughout gestation as well as in fetal liver. Obesity, a chronic inflammatory condition, is known to alter CYP enzyme expression in non-placental tissues. In the present study, we test the hypothesis that maternal obesity alters the distribution of CYP1A1 activity in feto-placental unit. Placentas were collected from non-obese (BMI <30) and obese (BMI > 30) women at term. Livers were collected from gestation day 130 fetuses of non-human primates fed either control diet or high-fat diet (HFD). Cytosol and microsomes were collected using differential centrifugation, and incubated with 7-ethoxyresorufin. The CYP1A1 specific activity (pmoles of resorufin formed/min/mg of protein) was measured at excitation/emission wavelength of 530/590 nm. Placentas of obese women had significantly reduced microsomal CYP1A1 activity compared to non-obese women (0.046 vs. 0.082; p <0.05); however no such effect was observed on cytosolic activity. Similarly, fetal liver from HFD fed mothers had significantly reduced microsomal CYP1A1 activity (0.44 ± 0.04 vs. 0.20 ± 0.10; p <0.05), with no significant difference in cytosolic CYP1A1 activity (control, 1.23 ± 0.20; HFD, 0.80 ± 0.40). Interestingly, multiple linear regression analyses of placental efficiency indicate cytosolic CYP1A1 activity is a main effect (5.67 ± 2.32 (β ± SEM); p = 0.022) along with BMI (-0.57 ± 0.26; p = 0.037), fetal gender (1.07 ± 0.26; p <0.001), and maternal age (0.07 ± 0.03; p = 0.011). In summary, while maternal obesity affects microsomal CYP1A1 activity alone, cytosolic activity along with maternal BMI is an important determinant of placental efficiency. Together, these data suggest that maternal lifestyle could have a significant impact on CYP1A1 activity, and hints at a possible role for CYP1A1 in feto-placental growth and thereby well-being of fetus.

    Original languageEnglish (US)
    Pages (from-to)1045-1051
    Number of pages7
    JournalPlacenta
    Volume33
    Issue number12
    DOIs
    StatePublished - Dec 2012

    Fingerprint

    Cytochromes
    Obesity
    Mothers
    High Fat Diet
    Placenta
    Liver
    Fetus
    Pregnancy
    Maternal Age
    Enzymes
    Microsomes
    Centrifugation
    Cytosol
    Primates
    Life Style
    Linear Models
    Regression Analysis
    Diet

    Keywords

    • Cytochrome P4501A
    • Cytosol
    • Human placenta
    • Maternal obesity
    • Microsomes

    ASJC Scopus subject areas

    • Obstetrics and Gynecology
    • Reproductive Medicine
    • Developmental Biology

    Cite this

    Dubois, B. N., O'Tierney-Ginn, P., Pearson, J., Friedman, J. E., Thornburg, K., & Cherala, G. (2012). Maternal obesity alters feto-placental cytochrome P4501A1 activity. Placenta, 33(12), 1045-1051. https://doi.org/10.1016/j.placenta.2012.09.008

    Maternal obesity alters feto-placental cytochrome P4501A1 activity. / Dubois, B. N.; O'Tierney-Ginn, P.; Pearson, J.; Friedman, J. E.; Thornburg, Kent; Cherala, G.

    In: Placenta, Vol. 33, No. 12, 12.2012, p. 1045-1051.

    Research output: Contribution to journalArticle

    Dubois, BN, O'Tierney-Ginn, P, Pearson, J, Friedman, JE, Thornburg, K & Cherala, G 2012, 'Maternal obesity alters feto-placental cytochrome P4501A1 activity', Placenta, vol. 33, no. 12, pp. 1045-1051. https://doi.org/10.1016/j.placenta.2012.09.008
    Dubois BN, O'Tierney-Ginn P, Pearson J, Friedman JE, Thornburg K, Cherala G. Maternal obesity alters feto-placental cytochrome P4501A1 activity. Placenta. 2012 Dec;33(12):1045-1051. https://doi.org/10.1016/j.placenta.2012.09.008
    Dubois, B. N. ; O'Tierney-Ginn, P. ; Pearson, J. ; Friedman, J. E. ; Thornburg, Kent ; Cherala, G. / Maternal obesity alters feto-placental cytochrome P4501A1 activity. In: Placenta. 2012 ; Vol. 33, No. 12. pp. 1045-1051.
    @article{d3c80831ab8b4c49b6073f517174110e,
    title = "Maternal obesity alters feto-placental cytochrome P4501A1 activity",
    abstract = "Cytochrome P4501A1 (CYP1A1), an important drug metabolizing enzyme, is expressed in human placenta throughout gestation as well as in fetal liver. Obesity, a chronic inflammatory condition, is known to alter CYP enzyme expression in non-placental tissues. In the present study, we test the hypothesis that maternal obesity alters the distribution of CYP1A1 activity in feto-placental unit. Placentas were collected from non-obese (BMI <30) and obese (BMI > 30) women at term. Livers were collected from gestation day 130 fetuses of non-human primates fed either control diet or high-fat diet (HFD). Cytosol and microsomes were collected using differential centrifugation, and incubated with 7-ethoxyresorufin. The CYP1A1 specific activity (pmoles of resorufin formed/min/mg of protein) was measured at excitation/emission wavelength of 530/590 nm. Placentas of obese women had significantly reduced microsomal CYP1A1 activity compared to non-obese women (0.046 vs. 0.082; p <0.05); however no such effect was observed on cytosolic activity. Similarly, fetal liver from HFD fed mothers had significantly reduced microsomal CYP1A1 activity (0.44 ± 0.04 vs. 0.20 ± 0.10; p <0.05), with no significant difference in cytosolic CYP1A1 activity (control, 1.23 ± 0.20; HFD, 0.80 ± 0.40). Interestingly, multiple linear regression analyses of placental efficiency indicate cytosolic CYP1A1 activity is a main effect (5.67 ± 2.32 (β ± SEM); p = 0.022) along with BMI (-0.57 ± 0.26; p = 0.037), fetal gender (1.07 ± 0.26; p <0.001), and maternal age (0.07 ± 0.03; p = 0.011). In summary, while maternal obesity affects microsomal CYP1A1 activity alone, cytosolic activity along with maternal BMI is an important determinant of placental efficiency. Together, these data suggest that maternal lifestyle could have a significant impact on CYP1A1 activity, and hints at a possible role for CYP1A1 in feto-placental growth and thereby well-being of fetus.",
    keywords = "Cytochrome P4501A, Cytosol, Human placenta, Maternal obesity, Microsomes",
    author = "Dubois, {B. N.} and P. O'Tierney-Ginn and J. Pearson and Friedman, {J. E.} and Kent Thornburg and G. Cherala",
    year = "2012",
    month = "12",
    doi = "10.1016/j.placenta.2012.09.008",
    language = "English (US)",
    volume = "33",
    pages = "1045--1051",
    journal = "Placenta",
    issn = "0143-4004",
    publisher = "W.B. Saunders Ltd",
    number = "12",

    }

    TY - JOUR

    T1 - Maternal obesity alters feto-placental cytochrome P4501A1 activity

    AU - Dubois, B. N.

    AU - O'Tierney-Ginn, P.

    AU - Pearson, J.

    AU - Friedman, J. E.

    AU - Thornburg, Kent

    AU - Cherala, G.

    PY - 2012/12

    Y1 - 2012/12

    N2 - Cytochrome P4501A1 (CYP1A1), an important drug metabolizing enzyme, is expressed in human placenta throughout gestation as well as in fetal liver. Obesity, a chronic inflammatory condition, is known to alter CYP enzyme expression in non-placental tissues. In the present study, we test the hypothesis that maternal obesity alters the distribution of CYP1A1 activity in feto-placental unit. Placentas were collected from non-obese (BMI <30) and obese (BMI > 30) women at term. Livers were collected from gestation day 130 fetuses of non-human primates fed either control diet or high-fat diet (HFD). Cytosol and microsomes were collected using differential centrifugation, and incubated with 7-ethoxyresorufin. The CYP1A1 specific activity (pmoles of resorufin formed/min/mg of protein) was measured at excitation/emission wavelength of 530/590 nm. Placentas of obese women had significantly reduced microsomal CYP1A1 activity compared to non-obese women (0.046 vs. 0.082; p <0.05); however no such effect was observed on cytosolic activity. Similarly, fetal liver from HFD fed mothers had significantly reduced microsomal CYP1A1 activity (0.44 ± 0.04 vs. 0.20 ± 0.10; p <0.05), with no significant difference in cytosolic CYP1A1 activity (control, 1.23 ± 0.20; HFD, 0.80 ± 0.40). Interestingly, multiple linear regression analyses of placental efficiency indicate cytosolic CYP1A1 activity is a main effect (5.67 ± 2.32 (β ± SEM); p = 0.022) along with BMI (-0.57 ± 0.26; p = 0.037), fetal gender (1.07 ± 0.26; p <0.001), and maternal age (0.07 ± 0.03; p = 0.011). In summary, while maternal obesity affects microsomal CYP1A1 activity alone, cytosolic activity along with maternal BMI is an important determinant of placental efficiency. Together, these data suggest that maternal lifestyle could have a significant impact on CYP1A1 activity, and hints at a possible role for CYP1A1 in feto-placental growth and thereby well-being of fetus.

    AB - Cytochrome P4501A1 (CYP1A1), an important drug metabolizing enzyme, is expressed in human placenta throughout gestation as well as in fetal liver. Obesity, a chronic inflammatory condition, is known to alter CYP enzyme expression in non-placental tissues. In the present study, we test the hypothesis that maternal obesity alters the distribution of CYP1A1 activity in feto-placental unit. Placentas were collected from non-obese (BMI <30) and obese (BMI > 30) women at term. Livers were collected from gestation day 130 fetuses of non-human primates fed either control diet or high-fat diet (HFD). Cytosol and microsomes were collected using differential centrifugation, and incubated with 7-ethoxyresorufin. The CYP1A1 specific activity (pmoles of resorufin formed/min/mg of protein) was measured at excitation/emission wavelength of 530/590 nm. Placentas of obese women had significantly reduced microsomal CYP1A1 activity compared to non-obese women (0.046 vs. 0.082; p <0.05); however no such effect was observed on cytosolic activity. Similarly, fetal liver from HFD fed mothers had significantly reduced microsomal CYP1A1 activity (0.44 ± 0.04 vs. 0.20 ± 0.10; p <0.05), with no significant difference in cytosolic CYP1A1 activity (control, 1.23 ± 0.20; HFD, 0.80 ± 0.40). Interestingly, multiple linear regression analyses of placental efficiency indicate cytosolic CYP1A1 activity is a main effect (5.67 ± 2.32 (β ± SEM); p = 0.022) along with BMI (-0.57 ± 0.26; p = 0.037), fetal gender (1.07 ± 0.26; p <0.001), and maternal age (0.07 ± 0.03; p = 0.011). In summary, while maternal obesity affects microsomal CYP1A1 activity alone, cytosolic activity along with maternal BMI is an important determinant of placental efficiency. Together, these data suggest that maternal lifestyle could have a significant impact on CYP1A1 activity, and hints at a possible role for CYP1A1 in feto-placental growth and thereby well-being of fetus.

    KW - Cytochrome P4501A

    KW - Cytosol

    KW - Human placenta

    KW - Maternal obesity

    KW - Microsomes

    UR - http://www.scopus.com/inward/record.url?scp=84869504722&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84869504722&partnerID=8YFLogxK

    U2 - 10.1016/j.placenta.2012.09.008

    DO - 10.1016/j.placenta.2012.09.008

    M3 - Article

    C2 - 23046808

    AN - SCOPUS:84869504722

    VL - 33

    SP - 1045

    EP - 1051

    JO - Placenta

    JF - Placenta

    SN - 0143-4004

    IS - 12

    ER -